Search research articles
Contact Us
Filters
Showing results (151-160 of 386) with videos related to
Page
of 39
Sort By:
The American Journal of Gastroenterology
|
September 15, 2023
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway
Priscila Santiago, Nayantara Coelho-Prabhu, Ryan Lennon, et al.
Journal of Crohn'S & Colitis
|
September 27, 2021
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
Amanda Ricciuto, Christopher A Lamb, Eric I Benchimol, et al.
Clinical and Translational Gastroenterology
|
December 22, 2023
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry
Hans H Herfarth, Anita Afzali, Monika Fischer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 21, 2010
TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis
F L Conforti, W Sproviero, I L Simone, et al.
Inflammatory Bowel Diseases
|
May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course
Stephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
Journal of Crohn'S & Colitis
|
May 18, 2025
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease
Arno R Bourgonje, Susanne Ibing, Alexandra E Livanos, et al.
Journal of Crohn'S & Colitis
|
June 27, 2024
Lemann Index for assessing bowel damage in Crohn's disease: a real world study
Eric Prado, Cindy C Y Law, Catherine Rowan, et al.
Inflammatory Bowel Diseases
|
January 15, 2022
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
Gilaad G Kaplan, Fox E Underwood, Stephanie Coward, et al.
Inflammatory Bowel Diseases
|
June 14, 2022
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting
Millie D Long, Anita Afzali, Monika Fischer, et al.
Gastroenterology
|
May 20, 2020
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J Brenner, Ryan C Ungaro, Richard B Gearry, et al.
Page
of 39
Search research articles
Search
Showing results (151-160 of 386) with videos related to
Sort By:
Page
of 39
The American Journal of Gastroenterology
|
September 15, 2023
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway
Priscila Santiago, Nayantara Coelho-Prabhu, Ryan Lennon, et al.
Journal of Crohn'S & Colitis
|
September 27, 2021
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
Amanda Ricciuto, Christopher A Lamb, Eric I Benchimol, et al.
Clinical and Translational Gastroenterology
|
December 22, 2023
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry
Hans H Herfarth, Anita Afzali, Monika Fischer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 21, 2010
TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis
F L Conforti, W Sproviero, I L Simone, et al.
Inflammatory Bowel Diseases
|
May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course
Stephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
Journal of Crohn'S & Colitis
|
May 18, 2025
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease
Arno R Bourgonje, Susanne Ibing, Alexandra E Livanos, et al.
Journal of Crohn'S & Colitis
|
June 27, 2024
Lemann Index for assessing bowel damage in Crohn's disease: a real world study
Eric Prado, Cindy C Y Law, Catherine Rowan, et al.
Inflammatory Bowel Diseases
|
January 15, 2022
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
Gilaad G Kaplan, Fox E Underwood, Stephanie Coward, et al.
Inflammatory Bowel Diseases
|
June 14, 2022
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting
Millie D Long, Anita Afzali, Monika Fischer, et al.
Gastroenterology
|
May 20, 2020
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J Brenner, Ryan C Ungaro, Richard B Gearry, et al.
Page
of 39